Self‐Reporting Fluorescent Salicylaldehyde‐Chlorambucil Conjugate As A Type II ICD Inducer for Cancer Vaccine

Minjie Zhang,Xin Jin,Meng Gao,Yunjiao Zhang,Ben Zhong Tang

DOI: https://doi.org/10.1002/adma.202205701

IF: 29.4

2022-07-26

Advanced Materials

Abstract:Immunogenic cell death (ICD) can activate the anticancer immune response and is highly attractive to improve cancer treatment efficacy. ICD is closely related with endoplasmic reticulum (ER) stress and a series of ICD inducers were recently reported based on ER‐targeted photodynamic/photothermal agents or metal complexes. However, these ER‐targeted ICD inducers suffer from complicated synthesis and heavy metal cytotoxicity. Inspired by the promising clinical potential of small organic molecules, herein, we develop an ER‐targeted fluorescent self‐reporting ICD inducer SA‐Cbl by simple conjugation of chemotherapeutic drug chlorambucil (Cbl) with salicylaldehyde (SA). SA‐Cbl can selectively accumulate in ER to induce rapid ROS generation and unfolded protein response process, which led to a fast release of damage‐associated molecular patterns (DAMPs) and efficient dendritic cells maturation. Meanwhile, the ER‐targeted accumulation and ER‐stress inducing process can be in situ monitored based on the turn‐on fluorescence of SA‐Cbl, which is highly pH and polarity‐sensitive and can selectively interact with ER proteins. Compared with traditional chemotherapy drug doxorubicin, the superior anticancer immunity effect of SA‐Cbl was verified via an in vivo tumor model. This study thus provides a new strategy for developing fluorescent self‐reporting ICD inducers by decoration of chemotherapeutic drugs with pH and polarity sensitive organic fluorophores. This article is protected by copyright. All rights reserved

materials science, multidisciplinary,chemistry, physical,physics, applied, condensed matter,nanoscience & nanotechnology